Antagonists of the TRPV1 receptor and uses thereof

Details Antagonists of the TRPV1 receptor and uses thereof Antagonists of the TRPV1 receptor and uses thereof

2007-12-12

2011-10-04

Chandrakumar, Nizal (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

08030504

ABSTRACT:
The present application is directed to compounds that are TRPV1 antagonists and have formula (I)wherein variables Ar1, L1, R1, R2, R3, R4, R5, Y1, Y2, and Y3, are as defined in the description, which are useful for treating disorders caused by or exacerbated by vanilloid receptor activity.

REFERENCES:
patent: 3647819 (1972-03-01), Kirchner
patent: 3647910 (1972-03-01), Jones et al.
patent: 3711610 (1973-01-01), Kirchner
patent: 3814711 (1974-06-01), Eloy et al.
patent: 4958026 (1990-09-01), Schoellkopf et al.
patent: 5362878 (1994-11-01), Chang et al.
patent: 5444038 (1995-08-01), James et al.
patent: 5646140 (1997-07-01), Sugg et al.
patent: 5656634 (1997-08-01), Chang et al.
patent: 5760246 (1998-06-01), Biller et al.
patent: 6001860 (1999-12-01), Hamanaka
patent: 6291476 (2001-09-01), Kordik et al.
patent: 6472414 (2002-10-01), Biller et al.
patent: 6511998 (2003-01-01), Kordik et al.
patent: 6555539 (2003-04-01), Reich et al.
patent: 6858577 (2005-02-01), Zhang et al.
patent: 6933311 (2005-08-01), Lee et al.
patent: 2004/0015784 (2004-01-01), Chidlovskii
patent: 2004/0157849 (2004-08-01), Lee et al.
patent: 2005/0119304 (2005-06-01), Yura et al.
patent: 418071 (1991-03-01), None
patent: 587180 (1994-03-01), None
patent: 591830 (1994-04-01), None
patent: 609960 (1994-08-01), None
patent: 1256574 (2002-11-01), None
patent: 1403255 (2004-03-01), None
patent: 1344579 (1963-11-01), None
patent: 2020280 (1979-11-01), None
patent: 4178362 (1992-06-01), None
patent: WO-9113874 (1991-09-01), None
patent: WO-9726240 (1997-07-01), None
patent: WO-9850347 (1998-11-01), None
patent: WO-0047577 (2000-08-01), None
patent: WO-0050387 (2000-08-01), None
patent: WO-0208221 (2002-01-01), None
patent: WO-03014064 (2003-02-01), None
patent: WO-03022809 (2003-03-01), None
patent: WO-03051274 (2003-06-01), None
patent: WO-03051275 (2003-06-01), None
patent: WO-03055484 (2003-07-01), None
patent: WO-03055648 (2003-07-01), None
patent: WO-03055848 (2003-07-01), None
patent: WO-03070247 (2003-08-01), None
patent: WO-03080578 (2003-10-01), None
patent: WO-03095420 (2003-11-01), None
patent: WO-03097586 (2003-11-01), None
patent: WO-2004052845 (2004-06-01), None
patent: WO-2004052846 (2004-06-01), None
patent: WO-2005002551 (2005-01-01), None
patent: WO-2005040100 (2005-05-01), None
patent: WO-2006094627 (2006-09-01), None
Wolff, Burger's medicinal Chemistry and Drug Discovery, vol. 1, Principles and Practice, John Wiley & sons, New York, 1997.
“IUPAC Commission on Nomenclature of Organic Chemistry Rules for the Nomenclature of Organic Chemistry, Section E: Stereochemistry (Recommendations 1974)”, Pure Appl Chem, 1976, vol. 45, 13-30.
Adams, E.P. et al. “Dialkylaminoalkylquinolines”, J.Chem.Soc. 1957, 3066-3071.
Berge, S.M. et al. “Journal of Pharmaceutical Sciences, Pharmaceutical Salts”, J Pharmaceutical Sciences, 1977, vol. 66, 1-19.
Cannon, J.G. et al. “Synthesis of N-alkyl derivatives of 4-(2′-aminothyl)indole”, J.Heterocyclic Chemistry, 1982, vol. 19, 1195-1199.
Caterina et al. “Impaired Nociception and Pain Sensation in Mice Lacking the Capsaicin Receptor”, Science, 2000, vol. 288, 306-313.
Caterina et al. “The Vanilloid Receptor: A Molecular Gateway to the Pain Pathway”, Annu Rev Neurosci, 2001, vol. 24, 487-517.
Caterina M.J. et al. “The Capsaicin Receptor: A Heat-Activated Ion Channel in the Pain Pathway”, Nature, 1997, vol. 389, 816-824.
Collier et al. “The abdominal constriction response and its suppression by analgesic drugs in the mouse”, Br J Pharmac Chemother, 1968, vol. 32, 295-310.
Craig, J. et al. “Derivatives of aminoisoquinolines”, J.Am.Chem Soc. 1942, vol. 64, 783-784.
Davies “Indazole Derivatives: The synthesis of various amino- and hydroxy-indazoles and derived sulphonic acids”, J.Chem.Soc, 1955, 2412-2423.
Davis et al. “Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia”, Nature, 2000, vol. 405, 183-187.
Edward B. Roche, (Editor). “Bioreversible Carriers in Drug Design”, American.
Endo et al. “Molecular Requirements for Epigenetic Modulators Synthesis of Active Fragments of Teleocidins and Lyngbyatoxin”, Chemical and Pharmaceutical Bulletin, 1982, vol. 30—Issue 9, 3457-3460.
Fieser et al. “A comparison of heterocyclic systems with benzene VI Quinines of the quinoline and isoquinoline series”, J .Amer.Chem. Soc. 1935, vol. 57, 1840-1844.
Forbes I.T. et al. “N-(1-methyl-5-indolyl)-N′-(3-pyridyl)urea hydrochloride: the first selective 5-HTsub l c receptor antagonist”, J.Med.Chem, 1993, vol. 36, 1104-1107.
Fowler, C. “Intravesical Treatment of Overactive Bladder”, Urology, 2000, vol. 55, 60-64.
Gall, et al. “171 On a few derivatives of heterocyclic carbonic acids IV Metal ions and biological action, 36th report”, Helv Chinn Acta, 1954, vol. 37, 90-94.
Gall, et al. “On a few derivatives of heterocyclic carbonic acids IV Metal ions and biological action, 36supth report,”, Helv Chim Acta, 1955, vol. 38—Issue 171, 1421-1423.
Giencke, et al, “Desmethyl(trifluormethyl)actinomycine”, Liebigs Ann Chem, 1990, vol. 6, 569-579.
Hayes et al. “Cloning and Functional Expression of a Human Orthologue of Rat Vanilloid Receptor-1”, Pain, 2000, vol. 88, 205-215.
Higuchi T. and Stella V. (Editors). “Pro-Drugs as Novel Delivery Systems”, ACS Symposium Series, 1975, vol. 14.
Honma Teruki, et al. “Structure-Based Generation of a New Class of Potent Cdk4 Inhibitors: New de Novo Design Strategy and Library Design”, Journal of Medicinal Chemistry, American Chemical Society, 2001, vol. 44, 4615-4627.
International Search Report for application No. PCT/US2003/0004187, Mailed on Feb. 7, 2003, 7 pages.
International Search Report for application No. PCT/US2004/0018590, Mailed on Sep. 30, 2004, 3 pages.
International Search Report for application No. PCT/US2004/0025109, Mailed on Sep. 12, 2004, 4 pages.
International Search Report for application No. PCT/US07/087163, Mailed on Jul. 21, 2008, 7 pages.
Kawasaki, et al. “A new approach to 4-(2-aminoethyl)indoles via Claisen ortho-amide rearrangement of 3-hydroxy-2-methoxyindolines”, J.Chem.Soc.Chem.Commun., 1990, vol. 10, 781-782.
Kumar, et al. “Antiparasitic agents: Part XV—synthesis of 2-substituted 1(3)H-imidazo[4,5-function]isoquinolines as anthelmintic agents”, Indian Journal of Chemistry, 1992, vol. 31B, 177-182.
Landsiedel-Maier, D. “Structure Activity Relationship of Homonchiral 7-Substituted 1-Aminoindans as 5-HT1A Receptor Ligands, XP002296522”, Archie Der Pharmazie, 1998, vol. 331, 59-71.
Lichtenthaler, et al. “Nucleosides 44 Benzo-separated Pyrazolopyrimidines: Expeditions Synthesis of [3,4-g] and [3,4-h]-linked Pyrazoloquinazolinones”, Tetrahedron Letters, 1981, vol. 22—Issue 44, 4397-4400.
Lila, et al. “Large scale preparation of protected 4-aminomethylbenzamidine Application to the synthesis of the thrombin inhibitor, melagatran”, Synth Comm, 1998, vol. 28, 4419-4429.
Mooney et al. “Potential antitumor agens, 10 Synthesis and biochemical properties of 5-N-alkylamino-,N,N-dialkylamino-, and N-alkylacetamido-1-formylisoquinoline thiosemicarbazones”, Journal of Medicinal Chemistry, 1974, vol. 17—Issue 11, 1145-1150.
Mukkala et al. “124. New Heteroaromatic Complexing Agents and Luminescence of Their Europium(III) and Terbium(III) Chelates”, Helvetica Chima Acta, 1992, vol. 75, 1621-1632.
Naruto et al. “Photo-induced Friedel-Crafts reactions IV Indoleacetic acids”, Chemical and Pharmaceutical Bulletin, 1972, vol. 20—Issue 10, 2163-2171.
Nolano et al. “Topical Capsaicin in Humans: Parallel Loss of Epidermal Nerve Fibers and Pain Sensation”, Pain, 1999, vol. 81, 135-145.
Nunn et al. “Semmler-Wolf Aromatization and Abnormal Beckmann and Schm

Affiliated with

Also associated with

Rating

Antagonists of the TRPV1 receptor and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antagonists of the TRPV1 receptor and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antagonists of the TRPV1 receptor and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4281739